Citeline Podcasts

Medtech Insight spoke with Leads.Healthcare’s Ben Modley about Germany’s evolving NUBs reimbursement scheme for innovative medical technologies, and the status of the fast-tracking scheme for promising yet not-fully-proven technologies for use in the ambulatory setting. Changes have been made to the former, while the latter at last appears to be on the cusp of some solid progress.

Medtech Insight spoke with Leads.Healthcare’s Ben Modley about Germany’s evolving NUBs reimbursement scheme for innovative medical technologies, and the status of the fast-tracking scheme for promising yet not-fully-proven technologies for use in the ambulatory setting. Changes have been made to the former, while the latter at last appears to be on the cusp of some solid progress.

Medtech Insight spoke with Leads.Healthcare’s Ben Modley about Germany’s evolving NUBs reimbursement scheme for innovative medical technologies, and the status of the fast-tracking scheme for promising yet not-fully-proven technologies for use in the ambulatory setting. Changes have been made to the former, while the latter at last appears to be on the cusp of some solid progress.

During this year’s Medical Device Innovation Consortium public forum, stakeholders presented their thoughts on how to improve clinical trial designs including a “virtual patient” model that proponents say could mean the need for fewer trial patients and faster time to market. MedTech Insight spoke to the researchers who developed the model to understand how this could change the industry.

During this year’s Medical Device Innovation Consortium public forum, stakeholders presented their thoughts on how to improve clinical trial designs including a “virtual patient” model that proponents say could mean the need for fewer trial patients and faster time to market. MedTech Insight spoke to the researchers who developed the model to understand how this could change the industry.

During this year’s Medical Device Innovation Consortium public forum, stakeholders presented their thoughts on how to improve clinical trial designs including a “virtual patient” model that proponents say could mean the need for fewer trial patients and faster time to market. MedTech Insight spoke to the researchers who developed the model to understand how this could change the industry.

On this week's podcast, Medtech Insight journalists discussed FDA approvals and approval trends, Trinity Biotech's 510(k) withdrawal for its point-of-care cardiac troponin assay, an HHS Inspector General look at the costs of recalled devices and more.

On this week's podcast, Medtech Insight journalists discussed FDA approvals and approval trends, Trinity Biotech's 510(k) withdrawal for its point-of-care cardiac troponin assay, an HHS Inspector General look at the costs of recalled devices and more.

On this week's podcast, Medtech Insight journalists discussed FDA approvals and approval trends, Trinity Biotech's 510(k) withdrawal for its point-of-care cardiac troponin assay, an HHS Inspector General look at the costs of recalled devices and more.

On this week's podcast, Medtech Insight journalists discuss Boston Scientific's acquisition of EndoChoice, a pivot by Circassia and some important FDA diabetes device approvals, including the first closed-loop artificial pancreas.